Navigating Your Health Journey: What to Know About How Much Is a Wegovy Shot

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Brand-name Wegovy can cost between $900 and $1,500 monthly without insurance coverage, making weight loss treatment financially inaccessible for many individuals seeking evidence-based GLP-1 therapy. PlexusDx offers a clinically equivalent alternative through licensed 503A compounding pharmacies, delivering the same active ingredient at a fraction of the typical price point. Understanding your options helps you make an informed decision about which semaglutide delivery method aligns with your health goals and budget.

Understanding the True Cost of Brand-Name Semaglutide Injections

Brand-name Wegovy pricing reflects decades of pharmaceutical research, marketing, and regulatory approval costs that manufacturers pass directly to consumers. Most patients without employer-sponsored GLP-1 coverage pay $800–$1,500 monthly, with costs remaining constant whether using a 0.25 mg starter dose or a 2.4 mg maintenance dose. Insurance coverage varies significantly by plan type; many policies classify weight loss medications as non-covered or require prior authorization with specific BMI thresholds. Even with insurance, copays often exceed $129-$389/mo per month due to high deductibles and formulary restrictions.

The financial burden creates a significant barrier to treatment adherence, which directly impacts long-term health outcomes. Clinical trials show that consistent GLP-1 therapy produces 15–22% body weight reduction over 68 weeks, but discontinuation—often due to cost—reverses these benefits within months. Understanding the full cost structure helps patients identify whether brand-name medications fit their budget or whether compounded alternatives provide equal clinical value at lower expense.

How Compounded Semaglutide Differs From Brand-Name Wegovy

Compounded semaglutide injections contain the identical active pharmaceutical ingredient as Wegovy, manufactured through licensed 503A compounding pharmacies under strict quality-control standards. The difference lies in manufacturing location and regulatory oversight: brand-name medications are produced in large-scale FDA facilities, while compounded versions are prepared in state-licensed pharmacies following USP guidelines and federal compounding regulations. Both delivery methods achieve bioequivalent results because the injectable semaglutide formulation itself—not the manufacturer's brand—drives clinical outcomes. PlexusDx sources all compounded medications exclusively from licensed 503A pharmacies to ensure consistent purity and potency.

Cost reduction does not mean reduced efficacy or safety; compounding eliminates expensive marketing campaigns, corporate overhead, and branded packaging while maintaining pharmaceutical-grade quality standards. Patients using compounded semaglutide from licensed pharmacies experience the same dose-dependent weight loss, appetite suppression, and metabolic benefits documented in major clinical trials. This allows individuals to access proven GLP-1 therapy without paying premium prices for brand recognition.

PlexusDx Semaglutide Pricing and Payment Options

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, with no insurance requirement, no membership fees, and service available across all 50 states. Your dose may need to go up, but your price won't—PlexusDx maintains flat monthly pricing regardless of whether your provider adjusts your injection dose during treatment progression. Monthly commitment plans provide predictable budgeting without surprise cost increases as your therapeutic needs evolve. HSA and FSA accounts cover PlexusDx medications fully, making compounded semaglutide an eligible health expense for tax-advantaged savings.

Patients uninsured or with high deductibles benefit most from direct-pay pricing that eliminates insurance company intermediaries and claim processing delays. PlexusDx also offers a Precision Peptide Genetic Test for $298, which identifies how your body's peptide pathways respond to GLP-1 compounds—enabling more personalized dosing strategies. This genetic insight costs significantly less than conventional pharmacogenomic testing while providing actionable data about your individual treatment response.

Genetic Testing for Personalized Semaglutide Therapy

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Traditional pharmacogenomic testing focuses on drug metabolism enzymes; PlexusDx's peptide-pathway genetic test directly measures the biological systems that GLP-1 medications target. This distinction means your genetic results inform dose selection based on how your brain's appetite centers will actually respond, rather than how your liver metabolizes the drug. Personalized dosing based on genetic predisposition improves treatment satisfaction and reduces side effects by matching your injection dose to your unique peptide physiology from day one.

Comparing Semaglutide to Other GLP-1 Weight Loss Options

Semaglutide represents the longest-established GLP-1 receptor agonist, with over 15 years of clinical use and the most extensive safety database among weight loss medications. Tirzepatide, a dual GLP-1/GIP receptor agonist, produces slightly greater weight loss (21% vs. 18% for semaglutide) but carries higher cost and remains newer to market with smaller long-term safety datasets. PlexusDx offers both compounded semaglutide injections and compounded tirzepatide injections, allowing your provider to select the medication best suited to your genetic profile and treatment goals. Oral formulations of both medications exist but require specific timing with food and water, limiting absorption compared to injected versions.

Microdose GLP-1 protocols, available through PlexusDx at $129 monthly, use lower semaglutide doses to minimize side effects while maintaining therapeutic weight loss benefits for patients with medication sensitivity or gastrointestinal concerns. Dual-compound options like GLP-Squared combine semaglutide and tirzepatide in a single injection, maximizing two receptor pathways simultaneously for patients who plateau on monotherapy. Your PlexusDx provider will recommend the formulation and dose that aligns with your genetic test results, medical history, and tolerance profile—ensuring you receive individualized care, not one-size-fits-all treatment.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

How much does a Wegovy shot cost monthly without insurance?

Brand-name Wegovy typically costs $900–$1,500 monthly for uninsured patients, with pricing remaining constant across all dose levels. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, representing 80–85% cost savings for clinically equivalent therapy.

Is compounded semaglutide as effective as brand-name Wegovy?

Yes—compounded semaglutide contains the identical active ingredient and produces equivalent clinical results documented in peer-reviewed trials, including 15–22% body weight reduction over 68 weeks. Efficacy depends on the medication itself, not the manufacturer's brand name, provided it comes from licensed 503A compounding pharmacies meeting USP standards.

Does PlexusDx charge more if my dose increases during treatment?

No. PlexusDx maintains flat monthly pricing regardless of dose adjustments—your dose may go up, but your price won't. This pricing model eliminates surprise cost increases as your provider optimizes your therapeutic dose over time.

Can I use HSA or FSA funds to pay for PlexusDx semaglutide?

Yes. PlexusDx compounded semaglutide injections are fully eligible for HSA and FSA reimbursement, allowing you to use tax-advantaged savings accounts to cover your medication costs.

What does the PlexusDx Precision Peptide Genetic Test reveal about my semaglutide response?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy Shot
• How Much Calcium Should Women Consume Daily For Optimal Bone Health
• Form Health Weight Loss
• Form Health Zepbound

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.